Your search returned 11 results.

Results
	1.	Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors: Van Nostrand, Douglas PMID: 31271271 Year: 2019 Citation: The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Giovanella L, van Nostrand D DOI: https://dx.doi.org/10.23736/S1824-4785.19.03191-1 Add to cart (remove)
	2.	Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors: Van Nostrand, Douglas PMID: 31160436 Year: 2019 Citation: Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D Add to cart (remove)
	3.	Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors: Van Nostrand, Douglas PMID: 30105931 Year: 2018 Citation: Thyroid. 28(9):1083-1093, 2018 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D DOI: https://dx.doi.org/10.1089/thy.2018.0048 Add to cart (remove)
	4.	Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors: Bethancourt, Evelyn Bikas, Athanasios Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 30361377 Year: 2019 Citation: Journal of Nuclear Medicine. 60(5):638-643, 2019 05. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.118.213256 Add to cart (remove)
	5.	Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors: Atkins, Francis Burman, Kenneth D Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard PMID: 26357962 Year: 2015 Citation: Thyroid. 25(12):1347-50, 2015 Dec. Institution: MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Endocrinology Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Validation Studies Form of publication: Journal Article All authors: Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2014.0616 Add to cart (remove)
	6.	Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. MedStar authors: Burman, Kenneth D Gomes-Lima, Cristiane J Jonklaas, Jacqueline Shobab, Leila Wartofsky, Leonard Zeymo, Alexander PMID: 31319763 Year: 2019 Citation: Thyroid. 29(9):1262-1268, 2019 09. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Feldman R, Gomes-Lima CJ, Jonklaas J, Shobab L, Wartofsky L, Zeymo A DOI: https://dx.doi.org/10.1089/thy.2019.0075 https://dx.doi.org/10.1089/thy.2019.0075 https://dx.doi.org/10.1089/thy.2019.0075 https://dx.doi.org/10.1089/thy.2019.0075 Add to cart (remove)
	7.	Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors: Van Nostrand, Douglas PMID: 30900516 Year: 2019 Citation: Thyroid. 29(4):461-470, 2019 04. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA DOI: https://dx.doi.org/10.1089/thy.2018.0597 Add to cart (remove)
	8.	Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?. MedStar authors: Bikas, Athanasios Burman, Kenneth D Gomes-Lima, Cristiane J Lee, Wen Shobab, Leila Wartofsky, Leonard Wu, Di Ylli, Dorina PMID: 33716974 Year: 2021 Citation: Frontiers in Endocrinology. 12:623182, 2021. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Pathology Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bikas A, Burman KD, Castro LC, Feldman R, Gomes-Lima CJ, Jensen K, Jonklaas J, Lee W, McCoy M, Rao SN, Shobab L, Vasko V, Wartofsky L, Wu D, Ylli D DOI: https://dx.doi.org/10.3389/fendo.2021.623182 Add to cart (remove)
	9.	Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors: Van Nostrand, Douglas PMID: 29650270 Year: 2018 Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D DOI: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 Add to cart (remove)
	10.	Bone metastasis from noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP); a case report. MedStar authors: Wartofsky, Leonard PMID: 34736430 Year: 2021 Citation: BMC Endocrine Disorders. 21(1):221, 2021 Nov 04. Institution: MedStar Health Research Institute Medline publication type: Case Reports Journal Article Form of publication: Journal Article All authors: Aghaee A, Fakhar Y, Khooei A, Mohammadzadeh Kosari H, Wartofsky L, Zakavi SR DOI: https://dx.doi.org/10.1186/s12902-021-00883-7 Add to cart (remove)
	11.	Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. MedStar authors: Barett, Christina Bikas, Athanasios Burman, Kenneth D Clark, Brandon G Desale, Sameer Gandhi, Rahul Jelinek, James S Kundra, Priya Mete, Mihriye O'Keefe, Kaitlyn Wartofsky, Leonard Wexler, Jason Wray, Lynette PMID: 26671977 Year: 2016 Citation: European Journal of Endocrinology. 174(3):373-80, 2016 Mar. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Radiology Medline publication type: Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barett C, Bikas A, Burman KD, Clark BG, Desale S, Gandhi R, Jelinek JS, Kundra P, Mete M, O'Keefe K, Wartofsky L, Wexler JA, Wray L DOI: http://dx.doi.org/10.1530/EJE-15-0930 Add to cart (remove)

Powered by Koha